Malignant lymphoma of testis
|
disease |
Neoplasms; Male Urogenital Diseases; Immune System Diseases; Endocrine System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
4
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
locally advanced squamous cell carcinoma of the skin
|
disease |
|
Neoplastic Process
|
4
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Tuberculosis, Miliary
|
disease |
Infections
|
Disease or Syndrome
|
5
|
1
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Non-small cell lung cancer stage IIIB
|
disease |
|
Neoplastic Process
|
11
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Sacculation
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Anatomical Abnormality
|
14
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Portal fibrosis
|
phenotype |
Digestive System Diseases
|
Disease or Syndrome
|
15
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Refractory Classic Hodgkin Lymphoma
|
disease |
|
Neoplastic Process
|
15
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Dendritic Cell Sarcoma, Follicular
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
16
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Epstein-Barr virus associated gastric carcinoma
|
disease |
|
Neoplastic Process
|
20
|
1
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Hantavirus infection in conditions classified elsewhere and of unspecified site
|
disease |
|
Disease or Syndrome
|
21
|
1
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type
|
disease |
|
Neoplastic Process
|
23
|
4
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Systemic immune activation
|
disease |
|
Disease or Syndrome
|
23
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Rheumatoid Nodule
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases
|
Acquired Abnormality
|
26
|
3
|
0.010 |
None |
< 0.001 |
1 |
|
2007 |
2007 |
T-cell/histiocyte rich large B-cell lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
28
|
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Lymphoma, Extranodal NK-T-Cell
|
disease |
Neoplasms
|
Neoplastic Process
|
33
|
2
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Sebaceous Adenocarcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
41
|
2
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
acute myeloid leukemia with multilineage dysplasia following myelodysplastic syndrome
|
disease |
|
Neoplastic Process
|
49
|
1
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Multinodular goiter
|
disease |
Neoplasms; Endocrine System Diseases
|
Disease or Syndrome
|
51
|
6
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Mediastinal (Thymic) Large B-Cell Lymphoma
|
disease |
Neoplasms; Respiratory Tract Diseases; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
66
|
1
|
0.040 |
None |
1.000 |
4 |
|
2010 |
2018 |
MSI-high
|
disease |
|
Neoplastic Process
|
83
|
9
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Amyloidosis cutis dyschromia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
84
|
1
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Stromal Neoplasm
|
disease |
Neoplasms
|
Neoplastic Process
|
86
|
1
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Inflammatory abnormality of the eye
|
disease |
|
Disease or Syndrome
|
88
|
1
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Anemia of chronic disease
|
phenotype |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
100
|
1
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Adenocarcinoma of rectum
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
103
|
1
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |